33 results
8-K
EX-99.1
CTLT
Catalent, Inc.
29 Aug 24
Catalent, Inc. Reports Fourth Quarter and Fiscal 2024 Results
7:47am
focused on life sciences, will provide. With Novo Holdings’ support, we look forward to further enhancing our innovative offerings to help people live
DEFA14A
CTLT
Catalent, Inc.
5 Feb 24
Additional proxy soliciting materials
5:22pm
and work together to continue developing, manufacturing and supplying innovative solutions and medicines.
We will work to provide updates when we
8-K
EX-99.1
00gb4yyp8v6o7q
29 Aug 23
Catalent, Inc. Reports Preliminary Fourth Quarter and Fiscal 2023 Results
7:07am
8-K
EX-10.1
jzg7 mw3na6sdu3
20 Jun 23
Catalent Appoints Matti Masanovich Senior Vice President & Chief Financial Officer
4:43pm
8-K
EX-10.1
knmo0lxdji531wj6w8ox
19 Sep 22
Departure of Directors or Certain Officers
4:41pm
8-K
EX-99.1
vfzumgg s68k5
5 Jul 22
Catalent Announces New Operating Structure
8:37am
8-K
EX-99.1
gvfgylo 96py
31 Aug 20
Catalent, Inc. Reports Fourth Quarter Fiscal 2020 Results
7:06am
424B5
5t26kgndey
12 Jun 20
Prospectus supplement for primary offering
4:16pm
424B5
velvs gt8a69
10 Jun 20
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
sfy16
30 Apr 20
Catalent Announces Next Generation of Cell & Gene Therapy Leadership
4:43pm
424B5
rzyrsc6a6o cj0q
3 Feb 20
Prospectus supplement for primary offering
4:26pm